Inactive Instrument
Stemcell Holdings, Inc. Share Price Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded
| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 23/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| +0.10% | +0.34% | +17.36% | -21.67% | 62.28B | |
| -5.35% | -0.27% | +60.73% | +206.96% | 60.59B | |
| +2.86% | +33.20% | +33.20% | +33.20% | 39.55B | |
| -1.84% | +7.78% | -55.82% | -63.26% | 36.8B | |
| -0.73% | +2.84% | +51.17% | -33.49% | 29.53B | |
| -4.10% | +3.47% | +46.21% | +66.40% | 21.68B | |
| +2.11% | +7.08% | +96.04% | -60.79% | 19.8B | |
| +1.24% | +1.04% | -4.09% | +126.32% | 16.96B | |
| -0.59% | -1.62% | +51.35% | +98.73% | 16.16B | |
| Average | -0.62% | +2.89% | +32.91% | +39.15% | 33.71B | |
| Weighted average by Cap. | -1.08% | +2.77% | +30.31% | +43.38% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.88M 2.66M 2.49M 4.66M 317M 4.73M 31.38M 12.23M 154M 12.53M 12.26M 535M | 6.18M 5.34M 4.92M 4.6M 8.63M 587M 8.76M 58.08M 22.64M 286M 23.19M 22.7M 990M |
| Net income | 1.4M 1.21M 1.12M 1.04M 1.96M 133M 1.99M 13.18M 5.14M 64.88M 5.26M 5.15M 225M | 2.41M 2.08M 1.92M 1.8M 3.36M 229M 3.42M 22.65M 8.83M 111M 9.04M 8.85M 386M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
